why choose us

First received: June 08, 2023

Clinical Trial: Brain-derived Neurotrophic Factor (BDNF) Single Nucleotide Gene Polymorphism and Nerve Growth Factor as Risk Factors That Increase Severity of Allergic Rhinitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Allergic Rhinitis

Study Type: OBSERVATIONAL


Official Title: Brain-derived Neurotrophic Factor (BDNF) Single Nucleotide Gene Polymorphism and Nerve Growth Factor as Risk Factors That Increase Severity of Allergic Rhinitis

Brief Summary: Allergic diseases such as asthma, allergic rhinitis (AR) and atopic dermatitis affect more than 25% of the world population and are the leading cause of illness in children.The complex interplay between genetic, environmental and immunological risk factors results in the manifestation of allergic diseases .The pathological presentation of allergic disease involves the activation of both the innate and adaptive immune systems, resulting in a multifaceted response in specific target tissues such as the airways .This…

Read more